Inflammatory Bowel Disease With Anemia
IRONDisc Medicine IncCatalyst overview
Research summary
This catalyst tracks a Phase 2 data readout for DISC-0974 (Hepcidin Suppression) in Inflammatory Bowel Disease With Anemia. The expected timing is based on the latest available company guidance and may change.
07/30/26:- Phase 2 IBD study progressing; initial data expected in 2027.
Verification
Confirm timing and program details against the company announcement or filing.